{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T17:15:55Z","timestamp":1793466955847,"version":"4.5.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,7,19]],"date-time":"2019-07-19T00:00:00Z","timestamp":1563494400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008373","name":"Takeda Pharmaceutical Company","doi-asserted-by":"publisher","award":["TAK-385"],"award-info":[{"award-number":["TAK-385"]}],"id":[{"id":"10.13039\/100008373","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fertstert.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.fertnstert.2019.07.013","type":"journal-article","created":{"date-parts":[[2019,10,5]],"date-time":"2019-10-05T23:07:00Z","timestamp":1570316820000},"page":"922-929.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":71,"title":["Relugolix, a novel oral gonadotropin-releasing hormone antagonist, in the treatment of pain symptoms associated with uterine fibroids: a randomized, placebo-controlled, phase 3 study in Japanese women"],"prefix":"10.1016","volume":"112","author":[{"given":"Yutaka","family":"Osuga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuaki","family":"Enya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentarou","family":"Kudou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Hoshiai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2019.07.013_bib1","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1111\/1471-0528.14640","article-title":"Epidemiology of uterine fibroids: a systematic review","volume":"124","author":"Stewart","year":"2017","journal-title":"BJOG"},{"key":"10.1016\/j.fertnstert.2019.07.013_bib2","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/01.AOG.0000136079.62513.39","article-title":"Uterine myomas: An overview of development, clinical features, and management","volume":"104","author":"Wallach","year":"2004","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2019.07.013_bib3","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0015-0282(16)45789-4","article-title":"Uterine leiomyomata: etiology, symptomatology, and management","volume":"36","author":"Buttram","year":"1981","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2019.07.013_bib4","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1742-4755-11-10","article-title":"Uterine leiomyoma: understanding the impact of symptoms on womens\u2019 lives","volume":"11","author":"Brito","year":"2014","journal-title":"Reprod Health"},{"key":"10.1016\/j.fertnstert.2019.07.013_bib5","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.bpobgyn.2017.10.001","article-title":"Alternatives to hysterectomy: the burden of fibroids and the quality of life","volume":"46","author":"Fortin","year":"2018","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.fertnstert.2019.07.013_bib6","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2147\/IJWH.S133212","article-title":"Patient-reported prevalence and symptomatic burden of uterine fibroids among women in the United States: Findings from a cross-sectional survey analysis","volume":"9","author":"Fuldeore","year":"2017","journal-title":"Int J Womens Health"},{"key":"10.1016\/j.fertnstert.2019.07.013_bib7","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1080\/03007995.2017.1372107","article-title":"Impact of uterine fibroid symptoms on health-related quality of life of US women: evidence from a cross-sectional survey","volume":"33","author":"Soliman","year":"2017","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.fertnstert.2019.07.013_bib8","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1472-6874-12-6","article-title":"Prevalence, symptoms and management of uterine fibroids: an international internet-based survey of 21,746 women","volume":"12","author":"Zimmermann","year":"2012","journal-title":"BMC Womens Health"},{"key":"10.1016\/j.fertnstert.2019.07.013_bib9","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1080\/17460441.2018.1417381","article-title":"Successes and failures of uterine leiomyoma drug discovery","volume":"13","author":"Ali","year":"2018","journal-title":"Expert Opin Drug Discov"},{"key":"10.1016\/j.fertnstert.2019.07.013_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1185\/03007995.2014.982246","article-title":"Contemporary management of uterine fibroids: focus on emerging medical treatments","volume":"31","author":"Singh","year":"2015","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.fertnstert.2019.07.013_bib11","doi-asserted-by":"crossref","DOI":"10.3390\/molecules22122188","article-title":"Recent development of nonpeptide GnRH antagonists","volume":"22","author":"Tukun","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.fertnstert.2019.07.013_bib12","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1126\/science.100883","article-title":"Hypophysial responses to continuous and intermittent delivery of hypopthalamic gonadotropin-releasing hormone","volume":"202","author":"Belchetz","year":"1978","journal-title":"Science"},{"key":"10.1016\/j.fertnstert.2019.07.013_bib13","author":"Hartmann"},{"key":"10.1016\/j.fertnstert.2019.07.013_bib14","doi-asserted-by":"crossref","first-page":"405","DOI":"10.3109\/09513590009167711","article-title":"Estradiol suppression and recovery during leuprolide acetate treatment in women as determined weekly by an ultrasensitive recombinant cell bioassay","volume":"14","author":"Larmore","year":"2000","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.fertnstert.2019.07.013_bib15","series-title":"Lupron Depot 3.75 mg (leuprolide acetate for depot suspension)","year":"2018"},{"key":"10.1016\/j.fertnstert.2019.07.013_bib16","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1093\/humupd\/dmw023","article-title":"Uterine fibroid management: from the present to the future","volume":"22","author":"Donnez","year":"2016","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2019.07.013_bib17","first-page":"CD007687","article-title":"Mifepristone for uterine fibroids","author":"Tristan","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.fertnstert.2019.07.013_bib18","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1097\/AOG.0b013e31818aa930","article-title":"Mifepristone for the treatment of uterine leiomyomas: a randomized controlled trial","volume":"112","author":"Carbonell Esteve","year":"2008","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2019.07.013_bib19","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1056\/NEJMoa1103182","article-title":"Ulipristal acetate versus placebo for fibroid treatment before surgery","volume":"366","author":"Donnez","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.fertnstert.2019.07.013_bib22","doi-asserted-by":"crossref","first-page":"4998","DOI":"10.1021\/jm200216q","volume":"54","author":"Miwa","year":"2011","journal-title":"J Med Chem"},{"key":"10.1016\/j.fertnstert.2019.07.013_bib23","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ejphar.2013.12.001","article-title":"Suppression of the hypothalamic-pituitary-gonadal axis by TAK-385 (relugolix), a novel, investigational, orally active, small molecule gonadotropin-releasing hormone (GnRH) antagonist: studies in human GnRH receptor knock-in mice","volume":"723","author":"Nakata","year":"2014","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.fertnstert.2019.07.013_bib24","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/AOG.0000000000003141","article-title":"Oral gonadotropin-releasing hormone antagonist relugolix compared with leuprorelin injections for uterine leiomyomas: a randomized controlled trial","volume":"133","author":"Osuga","year":"2019","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2019.07.013_bib25","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1210\/jc.2008-1695","article-title":"Suppression of gonadotropins and estradiol in premenopausal women by oral administration of the nonpeptide gonadotropin-releasing hormone antagonist elagolix","volume":"94","author":"Struthers","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2019.07.013_bib26","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1210\/jcem-57-1-62","article-title":"The dynamics of gonadotropin inhibition in women induced by an antagonistic analog of gonadotropin-releasing hormone","volume":"57","author":"Cetel","year":"1983","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2019.07.013_bib27","doi-asserted-by":"crossref","first-page":"86S","DOI":"10.1097\/01.AOG.0000514919.44544.95","article-title":"Phase 2 study of relugolix vs. placebo in heavy menstrual bleeding associated with uterine fibroids","volume":"129","author":"Hoshiai","year":"2017","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2019.07.013_bib28","first-page":"592","article-title":"Silencing MED12 gene reduces proliferation of human leiomyoma cells mediated via Wnt\/beta-catenin signaling pathway","volume":"158","author":"Al-Hendy","year":"2017","journal-title":"Endocrinology"},{"key":"10.1016\/j.fertnstert.2019.07.013_bib29","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1126\/science.1208930","article-title":"MED12, the mediator complex subunit 12 gene, is mutated at high frequency in uterine leiomyomas","volume":"334","author":"Makinen","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.fertnstert.2019.07.013_bib30","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/his.12039","article-title":"Prevalence of MED12 mutations in uterine and extrauterine smooth muscle tumours","volume":"62","author":"Matsubara","year":"2013","journal-title":"Histopathology"},{"key":"10.1016\/j.fertnstert.2019.07.013_bib31","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/modpathol.2013.243","article-title":"MED12 and HMGA2 mutations: two independent genetic events in uterine leiomyoma and leiomyosarcoma","volume":"27","author":"Bertsch","year":"2014","journal-title":"Mod Pathol"},{"key":"10.1016\/j.fertnstert.2019.07.013_bib32","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s00438-014-0938-x","article-title":"Novel MED12 gene somatic mutations in women from the southern United States with symptomatic uterine fibroids","volume":"290","author":"Halder","year":"2015","journal-title":"Mol Genet Genomics"},{"key":"10.1016\/j.fertnstert.2019.07.013_bib33","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1056\/NEJMoa1103180","article-title":"Ulipristal acetate versus leuprolide acetate for uterine fibroids","volume":"366","author":"Donnez","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.fertnstert.2019.07.013_bib34","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1089\/gtmb.2014.0273","article-title":"High-resolution melting analysis of MED12 mutations in uterine leiomyomas in Chinese patients","volume":"19","author":"Wang","year":"2015","journal-title":"Genet Test Mol Biomarkers"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028219306181?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028219306181?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T06:15:05Z","timestamp":1762150505000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028219306181"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S0015028219306181"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2019.07.013","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.736727172.793566666","asserted-by":"object"}]},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Relugolix, a novel oral gonadotropin-releasing hormone antagonist, in the treatment of pain symptoms associated with uterine fibroids: a randomized, placebo-controlled, phase 3 study in Japanese women","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2019.07.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a92019 The Authors. Published by Elsevier Inc. on behalf of the American Society for Reproductive Medicine.","name":"copyright","label":"Copyright"}]}}